Moreover, SSc patients responding to RTX treatment exhibit an upregulation of Dickkopf-1 (Dkk-1), a key inhibitor of the profibrotic Wnt pathway; of note, Dkk-1 is strikingly absent from SSc skin (119, 120). This evidence concerns the gene DKK1 and systemic sclerosis.